Murphy & Mullick Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Sell
3,363
-167
-5% -$50.7K 0.9% 26
2026
Q1
$754K Sell
3,530
-30
-0.8% -$6.71K 0.56% 47
2025
Q4
$609K Buy
3,560
+350
+11% +$54.4K 0.44% 55
2025
Q3
$438K Buy
3,210
+115
+4% +$12.2K 0.32% 70
2025
Q2
$294K Sell
3,095
-85
-3% -$6.74K 0.24% 90
2025
Q1
$231K Hold
3,180
– – 0.22% 105
2024
Q4
$230K Buy
+3,180
New +$241K 0.21% 101

Other funds holding LRCX

Murphy & Mullick Capital Management's LRCX Position: Q2 2026 in Review

Murphy & Mullick Capital Management reduced its Lam Research (LRCX) stake by 4.7% in Q2 2026, selling an estimated $50.7K and leaving 3,363 shares worth $1.46M. The position accounts for 0.9% of the portfolio, ranked #26.

Murphy & Mullick Capital Management first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Murphy & Mullick Capital Management held 3,363 shares of Lam Research worth $1.46M as of Q2 2026.
  • Murphy & Mullick Capital Management sold 167 Lam Research shares in Q2 2026, an estimated $50.7K.
  • Lam Research made up 0.9% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #26 holding.
  • Murphy & Mullick Capital Management first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.